Skip Navigation LinksHome > August 2014 - Volume 35 - Issue 8 > Adverse effects of radioactive iodine-131 treatment for diff...
Nuclear Medicine Communications:
doi: 10.1097/MNM.0000000000000132
Review Articles

Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma

Fard-Esfahani, Armaghana; Emami-Ardekani, Alirezaa; Fallahi, Babaka; Fard-Esfahani, Pezhmanb; Beiki, Davooda; Hassanzadeh-Rad, Armana; Eftekhari, Mohammada

Collapse Box

Abstract

Use of radioactive iodine is an essential adjuvant treatment strategy after thyroidectomy in patients with differentiated thyroid carcinoma. Although generally safe, radioiodine therapy has some potential side effects, classified as early and late complications, which we have reviewed in this paper. Early complications include gastrointestinal symptoms, radiation thyroiditis, sialadenitis/xerostomia, bone marrow suppression, gonadal damage, dry eye, and nasolacrimal duct obstruction. The late complications include secondary cancers, pulmonary fibrosis, permanent bone marrow suppression, and genetic effects. As 131I is an efficacious form of treatment that can significantly decrease the rate of mortality, recurrence, and metastasis, and as the side effects are often minor and well tolerated, radioiodine therapy remains the principal mode of treatment for patients with differentiated thyroid carcinoma.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.